247 results
Page 3 of 13
8-K
EX-99.1
39xz1bo
20 Oct 20
Results of Operations and Financial Condition
10:52am
8-K
EX-99.1
wh79 v3wvtb4m
13 Oct 20
Entry into a Material Definitive Agreement
8:44am
8-K
EX-99.3
sf5vze6ye sy059jkhw
1 Oct 20
Contingent Value Rights Agreement
8:42am
SC TO-T/A
EX-99
hhdr2
30 Sep 20
Third party tender offer statement (amended)
8:06am
8-K
EX-10.4
0q8mw72hjux2o7
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
SC TO-T
EX-99
08k3 ijp7ank3
31 Aug 20
Third party tender offer statement
8:46am
SC TO-T
EX-99
5m0fez5cwby
31 Aug 20
Third party tender offer statement
8:46am
SC TO-C
EX-99.1
61fradyar2ef2suu
10 Aug 20
Information about tender offer
9:52pm
8-K
EX-99.1
q3d9kav9o92a8s3
3 Aug 20
Ligand Reports Second Quarter 2020 Financial Results
7:48am
8-K
EX-99.1
zfus9eh
6 May 20
Ligand Reports First Quarter 2020 Financial Results
4:03pm
8-K
EX-99.1
0hfuuwc1wciavqno
2 Apr 20
Ligand Completes Acquisition of Icagen Core Assets, Partnered Programs
4:18pm
8-K
EX-99.1
mwq1d de64iv5d7t01t
11 Feb 20
Ligand Agrees to Acquire Core Assets, Partnered Programs and Ion Channel Technologies from Icagen
4:28pm
8-K
EX-99.1
f7c4l
6 Feb 20
Ligand Reports Fourth Quarter and Full Year 2019 Financial Results
4:05pm
8-K
EX-99.1
qh36u3wj7igq
5 Nov 19
Ligand Reports Third Quarter 2019 Financial Results
4:05pm
8-K
EX-99.1
66vcpn lpd
30 Jul 19
Ligand Reports Second Quarter 2019 Financial Results
8:13am